Risk of infections in bispecific antibody therapy for multiple myeloma: a comprehensive review of literature by Fahad Alshammari, Abdullah M. Alrajhi, Jude Howaidi

Get full text

Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects by Abdullah AlZahrani, Nada Alsuhebany, Imran K. Tailor, Abdullah M. Alrajhi

Get full text

Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature revie... by Alaa Eldein Yahia, Ibrahim Motabi, Abdullah A. Alsakkaf, Kamal Alzahrani, Laila M. Alsuhaibani, Bilal Albtoosh, Abdullah Khaled AlBathi, Abdullah M. Alrajhi

Get full text

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region... by Ayman Alhejazi, Ahmad Alhuraiji, Abdulnaser Nourallah, Abdulrahman Alshehri, Binyam Usman, Ghada ElGohary, Hafiz Malhan, Ibraheem Motabi, Ibraheem Motabi, Khalil Al Farsi, Mohammed Alshuaibi, Mohanad Diab, Mustaqeem Siddiqui, Ruba Yasin Taha, Tarek Abouzeid, Wesam Ahmed, Wesam Ahmed, Ahmed Ramadan Ali, Rasha Ghonema, Sana Faysal Elkhazin, Yousra Moussa, Abdullah M. Alrajhi, Abdullah M. Alrajhi, Magdy Rabea, Yahia Aktham, Nesreen Bawazeer, Ali Ahmed Ali, Mohamed Zahir Chouikrat

Get full text

Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study by Mai Alalawi, Abdullah M. Alrajhi, Walaa A. Alshahrani, Amal H. Alotaibi, Arwa Alhaj Issa, Areej Abumostafa, Zahra Alhaj Issa, Bashayer Alshehri, Ghadah Alyousif, Nora Alkhudair, Nada Alsuhebany, Mohammed Alzahrani, Abrar Alghamdi, Hessah Alrashidi, Batoul A. Alenazi, Shaden H. Alonazi, Abeer A. Alghamdi, Ramesh Vishwakarma, Mohammed S. Asiri, Abeer A. Alenazi, Moureq Alotaibi, Tariq Aldebasi, Khalid Al Sulaiman

Get full text